Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;11(8):831-847.
doi: 10.2217/rme-2016-0117. Epub 2016 Dec 2.

Pluripotent stem cells: the last 10 years

Erin A Kimbrel  1 , Robert Lanza  1
Affiliations
Free article
Review

Pluripotent stem cells: the last 10 years

Erin A Kimbrel et al. Regen Med. 2016 Dec.
Free article

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Regen Med. 2017 Mar;12(2):218. doi: 10.2217/rme-2016-0117e1. Epub 2017 Feb 1. Regen Med. 2017. PMID: 28143381 No abstract available.

Abstract

Pluripotent stem cells (PSCs) can differentiate into virtually any cell type in the body, making them attractive for both regenerative medicine and drug discovery. Over the past 10 years, technological advances and innovative platforms have yielded first-in-man PSC-based clinical trials and opened up new approaches for disease modeling and drug development. Induced PSCs have become the foremost alternative to embryonic stem cells and accelerated the development of disease-in-a-dish models. Over the years and with each new discovery, PSCs have proven to be extremely versatile. This review article highlights key advancements in PSC research, from 2006 to 2016, and how they will guide the direction of the field over the next decade.

Keywords: clinical trials; disease-in-a-dish models; drug screening; embryonic stem cells; gene editing; induced pluripotent stem cells.

PubMed Disclaimer

LinkOut - more resources